Form 4: HealthEquity Director Jon Kessler Reports Significant Stock Transactions

Director Jon Kessler reports acquisition and disposal of HealthEquity, Inc. common stock and holdings of derivative securities.

Summary

• On April 2, 2025, Jon Kessler, a director at HealthEquity, Inc., reported acquiring 205,055 shares of common stock at $0 and disposing of 409,557 shares.
• Following these transactions, Kessler directly owns 409,557 shares of common stock.
• Kessler also indirectly owns 101,235 shares through GKF, LLC.
• Kessler holds options to buy shares of common stock at prices of $41.28, $61.72, and $73.61, exercisable on March 27, 2027, March 27, 2028 and March 26, 2029 respectively.
• These options include 17,409 shares at $41.28, 23,929 shares at $61.72, and 38,343 shares at $73.61 directly owned.
• Additionally, Kessler indirectly owns options through GKF, LLC, including 34,820 shares at $41.28, 23,930 shares at $61.72, and 12,782 shares at $73.61.
• The restricted stock units vested as to 205,055 shares on April 2, 2025.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Management Comments

• The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for directors and officers of publicly traded companies, such as HealthEquity, to report changes in their beneficial ownership of the company's securities.
• Similar filings are made by executives at comparable companies like Teladoc Health or Accolade, when they engage in stock transactions.

Stakeholder Impact

• The transactions reported may influence investor perception of HealthEquity's stock, although individual insider transactions don't always have a significant impact.

Key Dates

Keywords

HealthEquity, HQY, Jon Kessler, Form 4, Stock Options, Common Stock, Director, GKF, LLC, Beneficial Ownership, Securities